Statistics

Total Visits

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i54

Select a period of time:

Number of views in the range

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i23

Views

Views
September 20251
October 20259
November 20251
December 20253
January 20267
February 20262
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
Finland5
United Kingdom3
Brazil3
Austria2
Australia1
Canada1
Germany1
Slovakia1
Senegal1
 

Top cities views

Views
Helsinki5
Charlotte1
Coral Springs1
Dakar1
Durrington1
Los Angeles1
Maringá1
Munich1
Phoenix1
Ponta Grossa1